ArticleBioData mining2026
TLEUDS: a cascade Dual-Transfer learning system with quality- and knowledge-enhanced for precise fetal CHD screening.
Article in BioData mining, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Congenital heart disease (CHD) is the most common major congenital anomaly and a leading cause of perinatal mortality and long-term neurodevelopmental disability globally, among which severe ductal dependent CHD (D-CHD) requires urgent clinical intervention due to the high risk of catastrophic cardiovascular collapse if undiagnosed. Despite the advancement of fetal echocardiography-based analysis models, there remains a lack of comprehensive and accurate evaluation approaches for D-CHD, especially for the precise differentiation of critical subtypes including coarctation of the aorta (CoA), interrupted aortic arch (IAA), and transposition of the great arteries (TGA). To address this gap, we developed the D-CHD Precision Screening System (TLEUDS) using 9,142 fetal aortic arch echocardiographic long-axis view images and 58 ultrasound clips from three medical institutions. Aiming to solve the challenges of uneven quality consistency and long-tail distribution in real-world ultrasound imaging data, TLEUDS adopts a cascaded Dual-Transfer learning framework for quality and knowledge enhancement, which implements a closed-loop screening process from initial disease detection (via the TEN-S module, a transfer version of EfficientNetV2-Screening) to detailed subtype-specific malformation screening (via the TY-PS module, a transfer version of YOLOv11-Precise Screening). Experimental results show that TLEUDS achieved a sensitivity of 0.988, 0.941, 0.966, and 0.900 for D-CHD overall, CoA, IAA, and TGA respectively, with corresponding specificities of 0.988, 0.987, 1.000, and 0.956, demonstrating state-of-the-art (SOTA) performance compared with general models. TLEUDS is expected to serve as a potential automated screening tool for tiered healthcare and computer-aided diagnosis of fetal D-CHD. Furthermore, the proposed quality and knowledge-enhanced cascaded Dual-Transfer learning framework fully leverages the “image quality distribution” and “structural prior knowledge” of fetal echocardiography, holding great potential for extension to other ultrasound image analysis domains.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.